EquipNet is working in partnership with Benecyte Inc. to auction surplus laboratory equipment. The sale will also feature surplus assets from other biotech companies. North Carolina based firm Benecyte Inc. develops allogeneic cytokine-induced killer (CIK) cells for cancer treatment. The online auction, including models by Becton Dickinson, Thermo, Tecan, Agilent Malvern, Bio-Tek and other manufacturers, will take place between the 10th and 17th of July.
Over 250 lots are available including: Stemcell Technologies Robosep fully automated cell separator, Thermo Scientific LTQ XL mass spectrometer with Agilent 1200 HPLC and Agilent DAD detector, Bio-Tek PowerWave HT UV-Vis microplate reader with washer and bio-stack, Agilent Technologies Bravo 16050-102 liquid handler with PC, Malvern Instruments Visosizer TD dispersion analyzer, Beckman Coulter VI-Cell XR cell viability analyzer, Thermo Fisher Ion GeneStudio S5 plus semiconductor sequencer, BD Rhapsody Scanner single-cell analysis system, Gyros Protein Technologies GyroLab Xp immunossay analyzer, Guava Technologies EasyCyte plus flow cytometer and much more. The assets are located in Durham, North Carolina and Canton, Massachusetts, and can be inspected by appointment with the auctioneer only.
EquipNet is a leading global asset management specialist, providing appraisal, auction and asset redeployment services to the chemical, industrial, electronics, consumer goods and pharmaceutical industries. EquipNet operates from 25 locations around the world and conducts business in more than 170 countries, with clients ranging from small businesses to multi-national corporations.